Acceptability of High-flow Nasal Oxygen to Relieve Dyspnea in Palliative Care: Pilot Study
Acceptability of High-flow Nasal Oxygen to Relieve Dyspnea in Palliative Care: Pilot Study
In palliative care, the relief of the dyspnea is necessary. Medications for the reduction of dyspnea have side effects. High-flow nasal cannula oxygen therapy (HFNC) is a new way to deliver oxygen. Investigators hypothesize that HNFC is an acceptable technic for the patient with dyspnea in palliative care.
A pilot study with 30 patients will be conducted. Acceptability of HNFC will be studied by the time of use by patients of the HNFC during one week. The effectiveness of HNFC in relieving dyspnea will be studied using Borg scale.
Pilot study for acceptability of high flow nasal cannula oxygen therapy in palliative care Population: 30 patients in palliative care (for lung cancer, terminal respiratory failure) who suffer from dyspnea and have oxygen therapy. Patients with curative care are excluded and patients who require non invasive ventilation.
An oral consent is asked.
Primary objective: acceptability of HNFC in patients with dyspnea in palliative care during one week
Secondary objectives:
Primary outcome: duration of use of the HNFC during 7 days
Secondary outcome:
Inclusion Criteria:
Exclusion Criteria: